Italy (IT)

Advancements in diagnosing oral potentially malignant disorders: leveraging Vision transformers for multi-class detection (2024) Vinayahalingam S, van Nistelrooij N, Rothweiler R, Tel A, Verhoeven T, Tröltzsch D, Kesting MR, et al. Journal article Corrigendum to “Kidney involvement in Rosai-Dorfman disease.” Kidney International 2023;103:231–232 (Kidney International (2023) 103(1) (231–232), (S0085253822008006), (10.1016/j.kint.2022.09.005)) (2024) Mazzariol M, Peyronel F, Fagni F, Minervini A, Santi R, Agostini S, Vaglio A Journal article, Erratum Future time perspectives of older adults as reflected through digital photocollage (2024) Elkarif T, Keisari S, Orkibi H, Piol S, Mola G, Lang F, Testoni I Journal article Wearable approaches for non-invasive monitoring of tendons: A scoping review (2024) Kárason H, Ritrovato P, Maffulli N, Boccaccini AR, Tortorella F Journal article, Review article Rapid weight loss and mood states in judo athletes: A systematic review (2024) Lakicevic N, Thomas E, Isacco L, Tcymbal A, Pettersson S, Roklicer R, Tubic T, et al. Journal article International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape (2024) Morgagni P, Bencivenga M, Carneiro F, Cascinu S, Derks S, Di Bartolomeo M, Donohoe C, et al. Journal article Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 (Gastric Cancer, (2024), 27, 4, (649-671), 10.1007/s10120-024-01479-5) (2024) Morgagni P, Bencivenga M, Carneiro F, Cascinu S, Derks S, Di Bartolomeo M, Donohoe C, et al. Journal article, Erratum Molecular communication data augmentation and deep learning based detection (2024) Scazzoli D, Vakilipoor Takaloo F, Magarini M Journal article Cryosphere–groundwater connectivity is a missing link in the mountain water cycle (2024) van Tiel M, Aubry-Wake C, Somers L, Andermann C, Avanzi F, Baraer M, Chiogna G, et al. Journal article 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article